Carlos Asuaje to join Lotte Giants of KBO

Carlos Asuaje
Getty Images
4 Comments

Rangers second baseman Carlos Asuaje is headed to Korea Baseball Organization, according to a report from Yahoo Sports’ Jeff Passan. Following a three-year campaign with the Padres, Asuaje was placed on waivers and subsequently claimed by the Rangers, who have yet to formalize the buyout required to move the infielder to KBO’s Lotte Giants.

Asuaje, 27, saw a sharp decline in his value during the 2018 season. He slashed a disappointing .196/.286/.280 with just 11 extra-base hits, 19 RBI and a .566 OPS, feeding into a career-worst -0.7 fWAR over 218 plate appearances. Despite a promising performance in 2017, he has yet to catch on in any meaningful way with a major-league team and stands to make a bigger impact for the Lotte Giants, who may be able to guarantee more consistent opportunities moving forward.

Final terms of the deal have yet to be reported. Asuaje is the fourth MLB player to join the Giants in recent years, a pool that included left-handers Félix Doubront and Brooks Raley and second baseman Andy Burns.

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
1 Comment

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.